Adolescent MenACWY Booster Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Participants will be randomized to receive one of the three doses of licensed MenACWY as a booster dose in adolescents. Serology will be collect at 3 time points; prior to the booster dose and 1 month and 1 year post‐vaccination to measure antibody levels. The participants are healthy students in grades 7‐9 who have not received their MenACWY vaccine yet and received their routine infant MenC vaccines per previous Canadian schedules.
Epistemonikos ID: 98f1460aee0b313c061a457ce60f542ff8be12e8
First added on: May 21, 2024